- Home
- IBOC vs TFX Comparison
IBOC vs TFX Comparison
Compare IBOC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBOC
- TFX
- Stock Information
- Founded
- IBOC 1966
- TFX 1943
- Country
- IBOC United States
- TFX United States
- Employees
- IBOC N/A
- TFX N/A
- Industry
- IBOC Major Banks
- TFX Medical/Dental Instruments
- Sector
- IBOC Finance
- TFX Health Care
- Exchange
- IBOC Nasdaq
- TFX Nasdaq
- Market Cap
- IBOC 4.2B
- TFX 4.8B
- IPO Year
- IBOC N/A
- TFX N/A
- Fundamental
- Price
- IBOC $66.23
- TFX $107.10
- Analyst Decision
- IBOC
- TFX Hold
- Analyst Count
- IBOC 0
- TFX 10
- Target Price
- IBOC N/A
- TFX $134.88
- AVG Volume (30 Days)
- IBOC 239.0K
- TFX 638.6K
- Earning Date
- IBOC 11-06-2025
- TFX 11-06-2025
- Dividend Yield
- IBOC 2.12%
- TFX 1.27%
- EPS Growth
- IBOC 5.13
- TFX N/A
- EPS
- IBOC 6.76
- TFX N/A
- Revenue
- IBOC $821,716,000.00
- TFX $3,189,988,000.00
- Revenue This Year
- IBOC N/A
- TFX $10.42
- Revenue Next Year
- IBOC N/A
- TFX $10.58
- P/E Ratio
- IBOC $9.79
- TFX N/A
- Revenue Growth
- IBOC 2.80
- TFX 5.42
- 52 Week Low
- IBOC $54.11
- TFX $102.58
- 52 Week High
- IBOC $76.91
- TFX $195.47
- Technical
- Relative Strength Index (RSI)
- IBOC 45.81
- TFX 31.16
- Support Level
- IBOC $64.37
- TFX $106.12
- Resistance Level
- IBOC $67.05
- TFX $114.20
- Average True Range (ATR)
- IBOC 1.63
- TFX 4.42
- MACD
- IBOC -0.09
- TFX -1.82
- Stochastic Oscillator
- IBOC 35.36
- TFX 14.82
About IBOC International Bancshares Corporation
International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.